TH5427 hydrochloride is a potent and selective NUDT5 inhibitor (IC50 = 29 nM) with 690-fold selectivity over MTH1; it blocks progesterone-dependent, PAR-derived nuclear ATP synthesis and subsequent chromatin remodeling, gene regulation, and proliferation in breast cancer cells.